Centene Corp (CNC) stock
CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 7/307% above fair value
$72.55−2.22 (-2.97%)
Close on Nov 17, 2026Market cap $35.92BP/E 24.8Yield –
Centene revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Centene's revenue for the twelve months ending Sep 30, 2026 was $203.90B, up 9.7% year over year. For fiscal 2025 it was $194.78B, up 19.4% from the year before. Over ten years it grew 23.9% a year on average. The highest annual figure on record is $194.78B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $194.78B | +19.4% |
| FY2024 | Dec 31, 2024 | $163.07B | +5.9% |
| FY2023 | Dec 31, 2023 | $154.00B | +6.5% |
| FY2022 | Dec 31, 2022 | $144.55B | +14.7% |
| FY2021 | Dec 31, 2021 | $125.98B | +13.4% |
| FY2020 | Dec 31, 2020 | $111.12B | +48.9% |
| FY2019 | Dec 31, 2019 | $74.64B | +24.2% |
| FY2018 | Dec 31, 2018 | $60.12B | +24.3% |
| FY2017 | Dec 31, 2017 | $48.38B | +19.1% |
| FY2016 | Dec 31, 2016 | $40.61B | +78.4% |
| FY2015 | Dec 31, 2015 | $22.76B | +37.4% |
| FY2014 | Dec 31, 2014 | $16.56B | +52.4% |
| FY2013 | Dec 31, 2013 | $10.86B | +33.9% |
| FY2012 | Dec 31, 2012 | $8.11B | +55.6% |
| FY2011 | Dec 31, 2011 | $5.21B | +17.2% |
| FY2010 | Dec 31, 2010 | $4.45B | +8.4% |
| FY2009 | Dec 31, 2009 | $4.10B | +21.9% |
| FY2008 | Dec 31, 2008 | $3.36B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $50.65B | +1.9% |
| Q2 FY2026 | Jun 30, 2026 | $53.58B | +9.9% |
| Q1 FY2026 | Mar 31, 2026 | $49.94B | +7.1% |
| Q4 FY2025 | Dec 31, 2025 | $49.73B | +21.9% |
| Q3 FY2025 | Sep 30, 2025 | $49.69B | +18.2% |
| Q2 FY2025 | Jun 30, 2025 | $48.74B | +22.4% |
| Q1 FY2025 | Mar 31, 2025 | $46.62B | +15.4% |
| Q4 FY2024 | Dec 31, 2024 | $40.81B | +3.4% |
| Q3 FY2024 | Sep 30, 2024 | $42.02B | +10.5% |
| Q2 FY2024 | Jun 30, 2024 | $39.84B | +5.9% |
| Q1 FY2024 | Mar 31, 2024 | $40.41B | +3.9% |
| Q4 FY2023 | Dec 31, 2023 | $39.46B | +11.0% |
| Q3 FY2023 | Sep 30, 2023 | $38.04B | +6.1% |
| Q2 FY2023 | Jun 30, 2023 | $37.61B | +4.7% |
| Q1 FY2023 | Mar 31, 2023 | $38.89B | +4.6% |
| Q4 FY2022 | Dec 31, 2022 | $35.56B | +9.2% |
| Q3 FY2022 | Sep 30, 2022 | $35.87B | +10.7% |
| Q2 FY2022 | Jun 30, 2022 | $35.94B | +15.8% |
| Q1 FY2022 | Mar 31, 2022 | $37.19B | +24.0% |
| Q4 FY2021 | Dec 31, 2021 | $32.57B | +15.1% |
| Q3 FY2021 | Sep 30, 2021 | $32.41B | +11.4% |
| Q2 FY2021 | Jun 30, 2021 | $31.03B | +12.0% |
| Q1 FY2021 | Mar 31, 2021 | $29.98B | +15.2% |
| Q4 FY2020 | Dec 31, 2020 | $28.29B | +50.0% |
| Q3 FY2020 | Sep 30, 2020 | $29.09B | +53.3% |
| Q2 FY2020 | Jun 30, 2020 | $27.71B | +51.0% |
| Q1 FY2020 | Mar 31, 2020 | $26.03B | +41.1% |
| Q4 FY2019 | Dec 31, 2019 | $18.86B | +13.9% |
| Q3 FY2019 | Sep 30, 2019 | $18.98B | +17.3% |
| Q2 FY2019 | Jun 30, 2019 | $18.36B | +29.4% |
| Q1 FY2019 | Mar 31, 2019 | $18.44B | +39.8% |
| Q4 FY2018 | Dec 31, 2018 | $16.56B | +29.3% |
| Q3 FY2018 | Sep 30, 2018 | $16.18B | +36.0% |
| Q2 FY2018 | Jun 30, 2018 | $14.18B | +18.6% |
| Q1 FY2018 | Mar 31, 2018 | $13.19B | +12.5% |
| Q4 FY2017 | Dec 31, 2017 | $12.81B | +7.5% |
| Q3 FY2017 | Sep 30, 2017 | $11.90B | – |
| Q2 FY2017 | Jun 30, 2017 | $11.95B | – |
| Q1 FY2017 | Mar 31, 2017 | $11.72B | – |
| Q4 FY2016 | Dec 31, 2016 | $11.91B | – |
See a number that looks wrong?